BCM
TBIO

Bridgeway Capital Management’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Bridgeway Capital Management’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,722
Closed -$29.5K – 1356
2024
Q1 		$29.5K Hold
3,722
– – ﹤0.01% 1285
2023
Q4 		$26.7K Sell
3,722
-2,778
-43% -$30.9K ﹤0.01% 1336
2023
Q3 		$122K Hold
6,500
– – ﹤0.01% 1191
2023
Q2 		$185K Hold
6,500
– – ﹤0.01% 1151
2023
Q1 		$363K Hold
6,500
– – 0.01% 960
2022
Q4 		$146K Hold
6,500
– – ﹤0.01% 1153
2022
Q3 		$194K Buy
+6,500
New +$229K 0.01% 1147

Other funds holding TBIO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
DWS
Dynamic Wealth Strategies Granite Bay, California $188M AUM 18.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bridgeway Capital Management's TBIO Position: Q2 2024 in Review

Bridgeway Capital Management sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q2 2024, closing a stake of 3,722 shares — an estimated $29.5K sold.

Bridgeway Capital Management first reported a position in TBIO in Q3 2022 and held it in 7 quarters. The position peaked at $363K in Q1 2023. 10 funds tracked by Wall St. Rank hold TBIO as of Q2 2024.

  • Bridgeway Capital Management reported no remaining Telesis Bio, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Bridgeway Capital Management sold 3,722 Telesis Bio, Inc. Common Stock shares in Q2 2024, an estimated $29.5K.
  • Bridgeway Capital Management first reported a position in Telesis Bio, Inc. Common Stock in Q3 2022 and held it in 7 quarters.
  • Bridgeway Capital Management's Telesis Bio, Inc. Common Stock position peaked at $363K in Q1 2023.
  • 10 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q2 2024.

Based on Bridgeway Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.